التفاصيل البيبلوغرافية
العنوان: |
Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy. |
المؤلفون: |
Bönnemann CG; National Institute of Neurological Disorders and Stroke, Bethesda, MD carsten.bonnemann@nih.gov., Belluscio BA; Pfizer, New York, NY., Braun S; Genethon, Evry, France., Morris C; Solid Biosciences, Charlestown, MA., Singh T; Sarepta Therapeutics, Cambridge, MA., Muntoni F; University College London Great Ormond Street Institute of Child Health, London, United Kingdom f.muntoni@ucl.ac.uk. |
المصدر: |
The New England journal of medicine [N Engl J Med] 2023 Jun 15; Vol. 388 (24), pp. 2294-2296. |
نوع المنشور: |
Letter |
اللغة: |
English |
بيانات الدورية: |
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
أسماء مطبوعة: |
Original Publication: Boston, Massachusetts Medical Society. |
مواضيع طبية MeSH: |
Dystrophin*/genetics , Dystrophin*/immunology , Genetic Therapy*/adverse effects , Genetic Therapy*/methods , Muscular Dystrophy, Duchenne*/genetics , Muscular Dystrophy, Duchenne*/immunology , Muscular Dystrophy, Duchenne*/therapy, Humans |
المشرفين على المادة: |
0 (Dystrophin) |
تواريخ الأحداث: |
Date Created: 20230614 Date Completed: 20230617 Latest Revision: 20230618 |
رمز التحديث: |
20240628 |
DOI: |
10.1056/NEJMc2212912 |
PMID: |
37314712 |
قاعدة البيانات: |
MEDLINE |